Efficacy of Neoadjuvant Chemotherapy and Radiotherapy for the Histology-confirmed Intracranial Germinoma: Preliminary Report.
- Author:
Young Ju NOH
1
;
Hak Jae KIM
;
Dae Seog HEO
;
Hee Yung SHIN
;
Il Han KIM
Author Information
1. Department of Therapeutic Radiology, Seoul National University College of Medicine, Seoul, Korea. ihkim@snu.ac.kr
- Publication Type:Original Article
- Keywords:
Intracranial germinoma;
Neoadjuvant chemotherapy;
Radiotherapy
- MeSH:
Adolescent;
Axis, Cervical Vertebra;
Basal Ganglia;
Brain;
Cerebrospinal Fluid;
Chemotherapy, Adjuvant;
Cyclophosphamide;
Drug Therapy*;
Etoposide;
Female;
Follow-Up Studies;
Germinoma*;
Humans;
Kidney;
Liver;
Magnetic Resonance Imaging;
Male;
Pineal Gland;
Pneumonia;
Radiotherapy*;
Recurrence;
Respiratory Insufficiency;
Thalamus
- From:The Journal of the Korean Society for Therapeutic Radiology and Oncology
2002;20(2):93-99
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: We intended to decrease late CNS reaction after radical radiotherapy for an intracranial germinoma by using combined neoadjuvant chemotherapy and involved-field radiotherapy. The efficacy in terms of its acute toxicity and short-term relapse patterns was analyzed. MATERIALS AND METHODS: Eighteen patients were treated with combined neoadjuvant chemotherapy and radiotherapy between 1995 and 2001. The chemotherapy regimen used was the Children's Cancer Group (CCG) 9921A (cisplatin, cyclophosphamide, VP-16, vincristine) for 5 patients younger than 16 years, BEP (bleomycin, VP-16, cisplatin) for 12 patients, and EP (VP-16, cisplatin) for 1 patient. The radiotherapy covered the whole craniospinal axis for 5 patients, the whole brain for 1, and the partial brain (involved field) for 12. the primary lesion received tumour doses between 3,960 and 5,400 cGy. RESULTS: The male to female ratio was 16:2 and the median age was 16 years old. The tumors were located in the pineal gland in 12 patients, in the suprasellar region in 1, in the basal ganglia in 1, in the thalamus in 1. Three patients had multiple lesions and ventricular seedings were shown at MRI. In 3 patients, tumor cells were detected in the cerebrospinal fluid and MRI detected a spinal seeding in 2 patients. The response to neoadjuvant chemotherapy was complete remission in 5 patients, partial remission in 12, and no response in 1. However, after radiotherapy, all except 1 patient experienced complete remission. The toxicity during or after chemotherapy greater than or equal to grade III was remarkable; hematologic toxicity was observed in 11 patients, liver toxicity in none, kidney toxicity in none, and gastrointestinal toxicity in one. One patient suffered from bleomycin-induced pneumonitis. Radiotherapy was therefore stopped and the patient eventually died of respiratory failure. The other 17 are alive without any evidence of disease or relapse during an average of 20 months follow-up. CONCLUSION: A high response rate and disease control was experienced, which was the same as observed other studies and the morbidity from chemotherapy-induced toxicity was similar. With these results, the results from adjuvant chemotherapy and involved-field radiotherapy cannot be concluded to be equal to those from extended-field radiotherapy. The long term follow-up study on later complications are required in order to draw definite conclusions on the optimal management with minimum side effects.
